Endocrine Health in Childhood Cancer Survivors
- PMID: 33131540
- DOI: 10.1016/j.pcl.2020.08.002
Endocrine Health in Childhood Cancer Survivors
Abstract
Endocrine late effects, including reproductive disorders and secondary thyroid cancer, have been reported in up to 50 %childhood cancer survivors (CCS) more than 5 years after treatment. Most endocrine disorders are amenable to treatment; awareness of symptoms is therefore of great importance. Recognition of these symptoms may be delayed however because many are nonspecific. Timely treatment of endocrine disorders improves quality of life in CCS and prevents possible consequences, such as short stature, bone and cardiovascular disorders, and depression. At-risk CCS must therefore be regularly and systematically monitored. This article provides a summary of the most commonly reported endocrine late effects in CCS.
Keywords: Bone health; Childhood cancer survivor; Growth hormone deficiency; Hypothyroidism; Late effects; Metabolic syndrome; Radiation effects; Secondary thyroid cancer.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure H.M. van Santen has received speakers fees from Pfizer BV and Ferring BV. The remaining authors have nothing to disclose.
Similar articles
-
Long-term and late treatment consequences: endocrine and metabolic effects.Curr Opin Support Palliat Care. 2017 Sep;11(3):205-213. doi: 10.1097/SPC.0000000000000289. Curr Opin Support Palliat Care. 2017. PMID: 28661901 Review.
-
Late endocrine effects of childhood cancer.Nat Rev Endocrinol. 2016 Jun;12(6):319-36. doi: 10.1038/nrendo.2016.45. Epub 2016 Apr 1. Nat Rev Endocrinol. 2016. PMID: 27032982 Review.
-
Endocrine Sequelae in Childhood Cancer Survivors.Endocrinol Metab Clin North Am. 2020 Dec;49(4):565-587. doi: 10.1016/j.ecl.2020.07.001. Epub 2020 Oct 13. Endocrinol Metab Clin North Am. 2020. PMID: 33153668 Review.
-
Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer.Best Pract Res Clin Endocrinol Metab. 2002 Jun;16(2):335-48. doi: 10.1053/beem.2002.0201. Best Pract Res Clin Endocrinol Metab. 2002. PMID: 12064896 Review.
-
Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study.Cancer. 2003 Feb 1;97(3):663-73. doi: 10.1002/cncr.11095. Cancer. 2003. PMID: 12548609
Cited by
-
Co-morbid sarcopenia and low bone mineral density in young paediatric cancer survivors.J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):2156-2163. doi: 10.1002/jcsm.13563. Epub 2024 Aug 20. J Cachexia Sarcopenia Muscle. 2024. PMID: 39164071 Free PMC article.
-
Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome.Blood Adv. 2022 May 10;6(9):2824-2834. doi: 10.1182/bloodadvances.2021006090. Blood Adv. 2022. PMID: 35196375 Free PMC article.
-
Antidepressants for the treatment of depression in people with cancer.Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD011006. doi: 10.1002/14651858.CD011006.pub4. Cochrane Database Syst Rev. 2023. PMID: 36999619 Free PMC article. Review.
-
Influencing factors of depressive symptoms in patients with malignant tumour.J Int Med Res. 2021 Dec;49(12):3000605211062450. doi: 10.1177/03000605211062450. J Int Med Res. 2021. PMID: 34894827 Free PMC article.
-
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice.Pituitary. 2021 Oct;24(5):810-827. doi: 10.1007/s11102-021-01173-0. Epub 2021 Jul 25. Pituitary. 2021. PMID: 34304361 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical